COVID-19 as a cause of immune thrombocytopenia

Neunert, 2011, The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia, Blood, 117, 4190, 10.1182/blood-2010-08-302984

Zulfiqar, 2020, Immune thrombocytopenic purpura in a patient with COVID-19, N Engl J Med, 10.1056/NEJMc2010472

Zea-Vera, 2017, Zika virus (ZIKV) infection related with immune thrombocytopenic purpura (ITP) exacerbation and antinuclear antibody positivity, Lupus, 26, 890, 10.1177/0961203316671816

Magdi, 2019, Severe immune thrombocytopenia complicated by intracerebral haemorrhage associated with coronavirus infection: a case report and literature review, Eur J Case Rep Intern Med, 6, 001155

Tang, 2020, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, J Thromb Haemost, 18, 844, 10.1111/jth.14768

Amgalan, 2020, Exploring possible mechanisms for COVID-19 induced thrombocytopenia: unanswered questions, J Thromb Haemost, 10.1111/jth.14832

Audia, 2017, Pathogenesis of immune thrombocytopenia, Autoimmun Rev, 16, 620, 10.1016/j.autrev.2017.04.012

Zhang, 2009, Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C–related immunologic thrombocytopenia, Blood, 113, 4086, 10.1182/blood-2008-09-181073

Zhao, 2020, Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019, Clin Infect Dis, 10.1093/cid/ciaa344

Gorse, 2020, Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses, J Med Virol, 92, 512, 10.1002/jmv.25715